200,000+ products from a single source!
sales@angenechem.com
186826-86-8 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1)
CAS No: 186826-86-8 Catalog No: AG00359Z MDL No:MFCD00949117
Product Description
Catalog Number:
AG00359Z
Chemical Name:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1)
CAS Number:
186826-86-8
Molecular Formula:
C21H25ClFN3O4
Molecular Weight:
437.8923
MDL Number:
MFCD00949117
IUPAC Name:
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride
InChI:
InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
InChI Key:
IDIIJJHBXUESQI-DFIJPDEKSA-N
SMILES:
COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.Cl
UNII:
C53598599T
Properties
Complexity:
727
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
2
Defined Bond Stereocenter Count:
0
Exact Mass:
437.152g/mol
Formal Charge:
0
Heavy Atom Count:
30
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
437.896g/mol
Monoisotopic Mass:
437.152g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
82.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Observations on conducting whole-cell patch clamping of the hERG cardiac K(+) channel in pure human serum. | Journal of applied toxicology : JAT 20170401 |
| Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model. | Cardiovascular toxicology 20160401 |
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response. | The Journal of pharmacology and experimental therapeutics 20140701 |
| QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation. | Journal of clinical pharmacology 20140401 |
| Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. | Toxicological sciences : an official journal of the Society of Toxicology 20131201 |
| Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry 20130215 |
| Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study. | Biomedical chromatography : BMC 20121101 |
| Identification of a novel resistance mutation in parE that confers high-level resistance to moxifloxacin in Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20121101 |
| Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study. | Scandinavian journal of infectious diseases 20121101 |
| Photodegradation of fluoroquinolones in surface water and antimicrobial activity of the photoproducts. | Water research 20121101 |
| In vitro susceptibility of Mycobacterium bovis against moxifloxacin. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20121101 |
| Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. | Internal and emergency medicine 20121001 |
| Seasonality of Clostridium difficile infections in Southern Germany. | Epidemiology and infection 20121001 |
| Fungal keratitis responsive to moxifloxacin monotherapy. | Cornea 20121001 |
| Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers. | Clinical therapeutics 20121001 |
| Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring? | The European respiratory journal 20121001 |
| 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. | Lancet (London, England) 20120915 |
| Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. | Journal of clinical pharmacology 20120901 |
| Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. | Respiratory medicine 20120901 |
| Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial. | Diagnostic microbiology and infectious disease 20120901 |
| Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. | Clinical therapeutics 20120901 |
| In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments. | Rapid communications in mass spectrometry : RCM 20120830 |
| Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. | World journal of gastroenterology 20120828 |
| Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin. | Journal of clinical pharmacology 20120801 |
| A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects. | International journal of cancer 20120801 |
| Moxifloxacin punctum plug for sustained drug delivery. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801 |
| Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers. | British journal of clinical pharmacology 20120801 |
| Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120801 |
| Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis. | Respirology (Carlton, Vic.) 20120801 |
| In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801 |
| Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. | Ocular immunology and inflammation 20120801 |
| Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. | International journal of clinical pharmacology and therapeutics 20120801 |
| [Sepsis. Update 2012]. | Deutsche medizinische Wochenschrift (1946) 20120801 |
| [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany]. | Infection 20120801 |
| New drug combination for TB is tested in unique trial. | BMJ (Clinical research ed.) 20120725 |
| Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. | Clinical & experimental ophthalmology 20120701 |
| Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. | The European respiratory journal 20120701 |
| Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120701 |
| Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. | Ophthalmology 20120701 |
| Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. | Antimicrobial agents and chemotherapy 20120701 |
| Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates. | The new microbiologica 20120701 |
| Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis. | Expert review of anti-infective therapy 20120701 |
| Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. | JAMA 20120613 |
| Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride. | European journal of drug metabolism and pharmacokinetics 20120601 |
| Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120601 |
| Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. | The European respiratory journal 20120601 |
| Safety of prophylactic intracameral moxifloxacin use in cataract surgery. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120601 |
| A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults. | Cancer chemotherapy and pharmacology 20120601 |
| Penetration of moxifloxacin into liver tissue. | International journal of antimicrobial agents 20120601 |
| Moxifloxacin safety: an analysis of 14 years of clinical data. | Drugs in R&D 20120601 |
| In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. | Biocontrol science 20120601 |
| Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515 |
| Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120515 |
| Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers. | Cancer chemotherapy and pharmacology 20120501 |
| Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. | The Journal of antibiotics 20120501 |
| gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. | The Journal of antimicrobial chemotherapy 20120501 |
| Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study. | Clinical drug investigation 20120501 |
| Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis. | Advances in therapy 20120501 |
| [Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients]. | Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20120501 |
| Thorough QT/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants. | Journal of clinical pharmacology 20120401 |
| Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia. | International journal of antimicrobial agents 20120401 |
| Moxifloxacin versus placebo modeling of the QT interval. | Journal of pharmacokinetics and pharmacodynamics 20120401 |
| Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization. | Pharmacotherapy 20120401 |
| QT effect of semagacestat at therapeutic and supratherapeutic doses. | International journal of clinical pharmacology and therapeutics 20120401 |
| Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. | Emerging infectious diseases 20120401 |
| Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium. | Expert review of anti-infective therapy 20120401 |
| Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty. | Advances in therapy 20120401 |
| Update on the cardiac safety of moxifloxacin. | Current drug safety 20120401 |
| Moxifloxacin-induced hypoglycemia in a non-diabetic patient. | Current drug safety 20120401 |
| Trial tests new combination of drugs to treat tuberculosis. | BMJ (Clinical research ed.) 20120320 |
| Reevaluation of moxifloxacin pharmacokinetics and their direct effect on the QT interval. | Journal of clinical pharmacology 20120301 |
| Pyrazinamide-induced sideroblastic anemia. | American journal of hematology 20120301 |
| Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. | The European respiratory journal 20120301 |
| [Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120301 |
| No evidence of QT prolongation with supratherapeutic doses of aleglitazar. | Journal of cardiovascular pharmacology 20120301 |
| Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. | International journal of antimicrobial agents 20120301 |
| [In vitro antibiotic susceptibility to fluoroquinolones]. | Archivos de la Sociedad Espanola de Oftalmologia 20120301 |
| Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database. | American heart journal 20120301 |
| PanACEA: a new approach to tuberculosis research. | The Lancet. Infectious diseases 20120301 |
| Design and evaluation of moxifloxacin hydrochloride ocular inserts. | Acta pharmaceutica (Zagreb, Croatia) 20120301 |
| Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. | The Journal of infectious diseases 20120215 |
| The steroids for corneal ulcers trial: study design and baseline characteristics. | Archives of ophthalmology (Chicago, Ill. : 1960) 20120201 |
| Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). | Archives of ophthalmology (Chicago, Ill. : 1960) 20120201 |
| Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201 |
| Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis. | The Pediatric infectious disease journal 20120201 |
| Spectrofluorimetric study of the interaction between europium(III) and moxifloxacin in micellar solution and its analytical application. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120201 |
| Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine. | The Journal of antimicrobial chemotherapy 20120201 |
| Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. | International journal of antimicrobial agents 20120201 |
| Determination of photostability and photodegradation products of moxifloxacin in the presence of metal ions in solutions and solid phase. Kinetics and identification of photoproducts. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20120201 |
| Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery. | International ophthalmology 20120201 |
| Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120201 |
| Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. | International journal of clinical practice 20120201 |
| Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201 |
| Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120201 |
| Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes. | British journal of pharmacology 20120101 |
| Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial. | The Journal of antimicrobial chemotherapy 20120101 |
| Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery. | The Journal of antimicrobial chemotherapy 20120101 |
| Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. | Journal of pediatric ophthalmology and strabismus 20120101 |
| Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. | Investigative ophthalmology & visual science 20120101 |
| Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis. | PloS one 20120101 |
| Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20120101 |
| Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection. | Indian journal of ophthalmology 20120101 |
| Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. | BMC infectious diseases 20120101 |
| Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection. | Acta dermatovenerologica Croatica : ADC 20120101 |
| Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions. | European journal of mass spectrometry (Chichester, England) 20120101 |
| Good penetration of moxifloxacin into human abscesses. | Pharmacology 20120101 |
| Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction. | Journal of electrocardiology 20120101 |
| Kinetic and thermodynamic studies of moxifloxacin hydrolysis in the presence and absence of metal ions in acidic solutions. | Acta poloniae pharmaceutica 20120101 |
| Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin. | Toxicology 20111218 |
| Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215 |
| Mycoplasma genitalium: should we treat and how? | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111215 |
| [Development of subcutaneous nodules after mesotherapy]. | Enfermedades infecciosas y microbiologia clinica 20111201 |
| Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111201 |
| Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections. | American journal of ophthalmology 20111201 |
| Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201 |
| A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201 |
| Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection. | Helicobacter 20111201 |
| In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201 |
| Simple and rapid liquid chromatography method for determination of moxifloxacin in saliva. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115 |
| A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections. | The Journal of antimicrobial chemotherapy 20111101 |
| Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study. | Clinical drug investigation 20111101 |
| Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis. | The Annals of pharmacotherapy 20111101 |
| Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review. | Eye & contact lens 20111101 |
| Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes. | Retina (Philadelphia, Pa.) 20111101 |
| Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience. | The European respiratory journal 20111001 |
| Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. | European journal of pediatrics 20111001 |
| Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication. | Journal of medical microbiology 20111001 |
| Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients. | The Journal of antimicrobial chemotherapy 20111001 |
| Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. | The Journal of antimicrobial chemotherapy 20111001 |
| Multidrug resistance in European Clostridium difficile clinical isolates. | The Journal of antimicrobial chemotherapy 20111001 |
| Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. | Ocular immunology and inflammation 20111001 |
| Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series. | Ocular immunology and inflammation 20111001 |
| Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001 |
| Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. | Ophthalmology 20111001 |
| A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin. | Korean journal of ophthalmology : KJO 20111001 |
| Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation. | Archives of pharmacal research 20111001 |
| Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. | The British journal of ophthalmology 20110901 |
| Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. | Journal of periodontology 20110901 |
| Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. | International journal of antimicrobial agents 20110901 |
| The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil. | Clinical pharmacology and therapeutics 20110901 |
| Moxifloxacin-dependent Torsades de Pointes. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110901 |
| Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110901 |
| [The effect of moxifloxacin on apoptosis of airway smooth muscle cells and mitochondria membrane potential]. | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110901 |
| Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. | Journal of clinical pharmacology 20110801 |
| Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones. | Anaerobe 20110801 |
| Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones. | Bioorganic & medicinal chemistry letters 20110801 |
| Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. | AJR. American journal of roentgenology 20110801 |
| [Current value of quinolones in Helicobacter pylori therapy]. | Zeitschrift fur Gastroenterologie 20110801 |
| The TB Alliance: overcoming challenges to chart the future course of TB drug development. | Future medicinal chemistry 20110801 |
| Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110701 |
| Creation of a knowledge management system for QT analyses. | Journal of clinical pharmacology 20110701 |
| Interface blood after descemet stripping automated endothelial keratoplasty. | Cornea 20110701 |
| T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. | Heart rhythm 20110701 |
| Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. | Ophthalmology 20110701 |
| Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. | Advances in therapy 20110701 |
| Interaction study of moxifloxacin and lomefloxacin with co-administered drugs. | Pakistan journal of pharmaceutical sciences 20110701 |
| A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. | Clinical therapeutics 20110701 |
| [The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection]. | Voenno-meditsinskii zhurnal 20110701 |
| Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country. | The Medical journal of Australia 20110606 |
| Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost. | Journal of clinical pharmacology 20110601 |
| Aclidinium bromide, a long-acting antimuscarinic, does not affect QT interval in healthy subjects. | Journal of clinical pharmacology 20110601 |
| Preventing endophthalmitis after cataract surgeries. | The British journal of ophthalmology 20110601 |
| Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. | International journal of antimicrobial agents 20110601 |
| Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis. | Therapeutic drug monitoring 20110601 |
| Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. | Journal of cataract and refractive surgery 20110601 |
| Intravenous moxifloxacin. Even more harmful than the oral form. | Prescrire international 20110601 |
| Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes. | The Korean journal of internal medicine 20110601 |
| Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin. | Journal of chemotherapy (Florence, Italy) 20110601 |
| Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans. | Medical mycology 20110501 |
| Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. | The Journal of antimicrobial chemotherapy 20110501 |
| Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110501 |
| Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501 |
| IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone. | International immunopharmacology 20110401 |
| Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110401 |
| Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium. | International journal of antimicrobial agents 20110401 |
| In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride. | The Journal of antimicrobial chemotherapy 20110401 |
| Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis. | Helicobacter 20110401 |
| Rational use of moxifloxacin for tuberculosis treatment. | The Lancet. Infectious diseases 20110401 |
| Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. | Archives of ophthalmology (Chicago, Ill. : 1960) 20110401 |
| Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases. | Archives of dermatology 20110401 |
| [Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401 |
| Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium. | Future microbiology 20110401 |
| Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20110401 |
| Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases. | Die Pharmazie 20110401 |
| Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. | Investigative ophthalmology & visual science 20110325 |
| [Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation]. | Revue medicale suisse 20110316 |
| Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines. | Bioorganic & medicinal chemistry letters 20110315 |
| High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. | Analytical chemistry 20110315 |
| Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20110310 |
| Perioperative moxifloxacin treatment in rats subjected to deep hypothermic circulatory arrest: reduction in cerebral inflammation but without improvement in cognitive performance. | The Journal of thoracic and cardiovascular surgery 20110301 |
| Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. | The Journal of antimicrobial chemotherapy 20110301 |
| Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. | The Journal of antimicrobial chemotherapy 20110301 |
| Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. | The Journal of infection 20110301 |
| Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosis. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110301 |
| Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses. | American journal of veterinary research 20110301 |
| Torticollis in mice intravenously infected with Mycobacterium tuberculosis. | Journal of the American Association for Laboratory Animal Science : JAALAS 20110301 |
| In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. | Allergy 20110201 |
| Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. | European journal of clinical pharmacology 20110201 |
| Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. | FEMS immunology and medical microbiology 20110201 |
| Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. | Dermatology (Basel, Switzerland) 20110201 |
| Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study. | Helicobacter 20110201 |
| Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. | Emerging infectious diseases 20110201 |
| Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin. | Veterinary microbiology 20110110 |
| Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. | Investigative ophthalmology & visual science 20110105 |
| Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. | Shock (Augusta, Ga.) 20110101 |
| Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta. | European journal of clinical pharmacology 20110101 |
| Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. | Journal of periodontology 20110101 |
| Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. | Cornea 20110101 |
| Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis. | Drugs 20110101 |
| Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection. | Journal of gastroenterology and hepatology 20110101 |
| Relevance of aqueous humor concentrations of fluoroquinolones. | Journal of cataract and refractive surgery 20110101 |
| Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20110101 |
| Vitreous and aqueous penetration of orally and topically administered moxifloxacin. | Ophthalmic research 20110101 |
| [Highlights of the Congress of the National Infectious Disease Medicine Days 2010]. | Medecine et maladies infectieuses 20110101 |
| Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis. | Retina (Philadelphia, Pa.) 20110101 |
| Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys. | Journal of pharmacological and toxicological methods 20110101 |
| The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. | Clinical drug investigation 20110101 |
| Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study. | BMC pulmonary medicine 20110101 |
| Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system. | mBio 20110101 |
| A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. | International journal of chronic obstructive pulmonary disease 20110101 |
| The thorough QT study: let's be precise. | Cardiology journal 20110101 |
| Improving the precision of QT measurements. | Cardiology journal 20110101 |
| A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress. | PloS one 20110101 |
| Moxifloxacin-induced delirium with hallucinations. | Psychosomatics 20110101 |
| Rhodococcus equi infection after reduction mammaplasty in an immunocompetent patient. | Revista do Instituto de Medicina Tropical de Sao Paulo 20110101 |
| Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis. | BMC structural biology 20110101 |
| Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone. | International journal of immunopathology and pharmacology 20110101 |
| Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101 |
| [Present and future in the use of anti-tubercular drugs]. | Pneumologia (Bucharest, Romania) 20110101 |
| High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215 |
| Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101201 |
| Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201 |
| Can intraocular lenses deliver antibiotics intracamerally? | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201 |
| Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections. | Journal of cataract and refractive surgery 20101201 |
| Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. | Current eye research 20101201 |
| Half-century-old TB drugs get a facelift in new cocktails. | Nature medicine 20101201 |
| [Chinfloxacin hydrochloride inhibits HERG potassium channel at open state]. | Yao xue xue bao = Acta pharmaceutica Sinica 20101201 |
| Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers. | Journal of clinical pharmacology 20101101 |
| Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies. | Journal of clinical pharmacology 20101101 |
| In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101 |
| Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy. | Cornea 20101101 |
| Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. | BJOG : an international journal of obstetrics and gynaecology 20101101 |
| Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. | American journal of ophthalmology 20101101 |
| Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis. | Eye & contact lens 20101101 |
| Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. | Pediatrics 20101101 |
| Fluoroquinolones in the management of community-acquired pneumonia in primary care. | Expert review of anti-infective therapy 20101101 |
| [Use of moxifloxacin in tuberculosis regimen in a French teaching hospital]. | Medecine et maladies infectieuses 20101001 |
| Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections. | Surgical infections 20101001 |
| Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia. | International journal of antimicrobial agents 20101001 |
| Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding. | Expert opinion on pharmacotherapy 20101001 |
| Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control. | Clinical pharmacology and therapeutics 20101001 |
| Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20101001 |
| Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001 |
| [The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis]. | Archivos de la Sociedad Espanola de Oftalmologia 20101001 |
| An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100915 |
| Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study. | Acta oto-laryngologica 20100901 |
| Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients. | Journal of cataract and refractive surgery 20100901 |
| Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model. | Japanese journal of ophthalmology 20100901 |
| Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers. | Acta pharmaceutica (Zagreb, Croatia) 20100901 |
| [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]. | Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20100801 |
| Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves. | Research in veterinary science 20100801 |
| Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters. | Pulmonary pharmacology & therapeutics 20100801 |
| Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan. | The Journal of hospital infection 20100801 |
| Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. | Eye (London, England) 20100801 |
| Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone. | International journal of antimicrobial agents 20100801 |
| Oritavancin, a new lipoglycopeptide antibiotic: results from a thorough QT study. | Journal of clinical pharmacology 20100801 |
| Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing. | European journal of clinical pharmacology 20100801 |
| Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. | The Journal of antimicrobial chemotherapy 20100801 |
| Antibiotic resistance of subgingival species in chronic periodontitis patients. | Journal of periodontal research 20100801 |
| Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line. | International journal of oncology 20100801 |
| Electrochemical determination of gatifloxacin, moxifloxacin and sparfloxacin fluoroquinolonic antibiotics on glassy carbon electrode in pharmaceutical formulations. | Drug testing and analysis 20100801 |
| A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100801 |
| Doxycycline failure in lymphogranuloma venereum. | Sexually transmitted infections 20100801 |
| Severe corneal changes following intravitreal injection of bevacizumab. | Ocular immunology and inflammation 20100801 |
| Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model. | Journal of chemotherapy (Florence, Italy) 20100801 |
| Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp. | Journal of chemotherapy (Florence, Italy) 20100801 |
| Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100801 |
| [Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections]. | The Japanese journal of antibiotics 20100801 |
| [R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]. | Medecine et maladies infectieuses 20100701 |
| Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. | International journal of antimicrobial agents 20100701 |
| Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection. | Combinatorial chemistry & high throughput screening 20100701 |
| Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization. | Clinical pharmacology and therapeutics 20100701 |
| Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. | Cornea 20100701 |
| Spontaneous subconjunctival abscess because of Haemophilus influenzae. | Cornea 20100701 |
| Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. | Wiener klinische Wochenschrift 20100701 |
| Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects. | British journal of clinical pharmacology 20100701 |
| Fungal keratitis associated with ocular rosacea. | International ophthalmology 20100601 |
| A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. | Anaerobe 20100601 |
| Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration. | Research in veterinary science 20100601 |
| Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. | Intensive care medicine 20100601 |
| In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species. | Antimicrobial agents and chemotherapy 20100601 |
| Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601 |
| Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime. | The journal of obstetrics and gynaecology research 20100601 |
| Tsukamurella: an emerging opportunistic ocular pathogen. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20100601 |
| Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs. | Analytica chimica acta 20100514 |
| Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells. | Eye (London, England) 20100501 |
| Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles. | Journal of pharmaceutical and biomedical analysis 20100501 |
| Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients. | Journal of clinical pharmacology 20100501 |
| Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study. | Clinical pharmacology and therapeutics 20100501 |
| Statistical characteristics of moxifloxacin-induced QTc effect. | Journal of biopharmaceutical statistics 20100501 |
| Statistical consideration in testing for assay sensitivity in a 'thorough' QT study. | Journal of biopharmaceutical statistics 20100501 |
| Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials. | Journal of biopharmaceutical statistics 20100501 |
| Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al. | Journal of biopharmaceutical statistics 20100501 |
| Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA. | Emerging infectious diseases 20100501 |
| Thorough QT study of the effect of fesoterodine on cardiac repolarization. | International journal of clinical pharmacology and therapeutics 20100501 |
| Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. | The Laryngoscope 20100501 |
| Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. | American journal of veterinary research 20100501 |
| Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis. | Journal of cataract and refractive surgery 20100501 |
| Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone. | Journal of cataract and refractive surgery 20100501 |
| Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense. | Australian veterinary journal 20100501 |
| [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents]. | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100501 |
| Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates. | Carbohydrate research 20100419 |
| Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors. | Biochemical pharmacology 20100415 |
| Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery. | Ophthalmology 20100401 |
| Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials. | Paediatric drugs 20100401 |
| [Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis]. | Journal francais d'ophtalmologie 20100401 |
| Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates. | Diagnostic microbiology and infectious disease 20100401 |
| Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. | The Annals of pharmacotherapy 20100401 |
| Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401 |
| Red eye, blurry vision, and cough. | The Journal of family practice 20100401 |
| Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers. | British journal of clinical pharmacology 20100401 |
| Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method. | Journal of analytical toxicology 20100401 |
| [Fatal acute hepatitis and cholestasis associated with liver disease]. | Medicina clinica 20100320 |
| Update in tuberculosis 2009. | American journal of respiratory and critical care medicine 20100315 |
| Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium. | Archives of toxicology 20100301 |
| Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. | The Journal of antimicrobial chemotherapy 20100301 |
| A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease. | International journal of STD & AIDS 20100301 |
| Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100201 |
| Synthesis and evaluation of (99m)Tc-moxifloxacin, a potential infection specific imaging agent. | Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20100201 |
| Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin. | Current medical research and opinion 20100201 |
| Activity of various drugs alone or in combination against Mycobacterium fortuitum. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100201 |
| Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis. | The Australasian journal of dermatology 20100201 |
| Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis. | Journal of periodontology 20100201 |
| [Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection]. | Zhonghua yi xue za zhi 20100112 |
| [Efficacy of moxifloxacin-based triple therapy to eradicate Helicobacter pylori infection]. | Zhonghua yi xue za zhi 20100112 |
| In vitro elution of moxifloxacin from cancellous bone allografts. | Journal of biomedical materials research. Part A 20100101 |
| Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India. | Eye (London, England) 20100101 |
| Use of a mydriatic cocktail with a wick for preoperative mydriasis in cataract surgery: a prospective randomised controlled trial. | Eye (London, England) 20100101 |
| Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101 |
| Moxifloxacin associated vanishing bile duct syndrome. | Journal of clinical gastroenterology 20100101 |
| Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks). | British journal of pharmacology 20100101 |
| Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. | Journal of medical microbiology 20100101 |
| The use of baseline covariates in crossover studies. | Biostatistics (Oxford, England) 20100101 |
| Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100101 |
| A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers. | American journal of therapeutics 20100101 |
| Besifloxacin ophthalmic suspension 0.6%. | Drugs 20100101 |
| Systemic anaphylaxis caused by moxifloxacin. | Allergologia et immunopathologia 20100101 |
| Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study. | Journal of pharmacological and toxicological methods 20100101 |
| Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. | Respiratory research 20100101 |
| Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. | Canadian journal of microbiology 20100101 |
| Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens. | Advances in therapy 20100101 |
| Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations. | Chemotherapy 20100101 |
| Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study. | Clinical drug investigation 20100101 |
| Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. | Annals of clinical microbiology and antimicrobials 20100101 |
| Prulifloxacin ECG study. | Clinical drug investigation 20100101 |
| [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains]. | Mikrobiyoloji bulteni 20100101 |
| Legionnaires' disease mimicking swine influenza (H1N1) pneumonia during the 'herald wave' of the pandemic. | Heart & lung : the journal of critical care 20100101 |
| Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals. | Journal of pharmacological and toxicological methods 20100101 |
| Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis. | The Annals of pharmacotherapy 20100101 |
| [Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age]. | Medycyna doswiadczalna i mikrobiologia 20100101 |
| Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. | Clinical drug investigation 20100101 |
| Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power. | Journal of pharmacological and toxicological methods 20100101 |
| Biopsy proven acute interstitial nephritis after treatment with moxifloxacin. | BMC nephrology 20100101 |
| The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model. | mBio 20100101 |
| Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin. | Chemotherapy 20100101 |
| A role for spleen monocytes in post-ischemic brain inflammation and injury. | Journal of neuroinflammation 20100101 |
| [Moxifloxacin and hepatic toxicity]. | Gastroenterologia y hepatologia 20091201 |
| In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20091201 |
| Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus. | Research in microbiology 20091201 |
| Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. | Anaerobe 20091201 |
| Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. | Eye (London, England) 20091201 |
| Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091201 |
| Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. | Therapeutic advances in respiratory disease 20091201 |
| Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals. | Expert opinion on investigational drugs 20091201 |
| Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. | Journal of cataract and refractive surgery 20091201 |
| Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201 |
| Effect of cefuroxime and moxifloxacin on Staphylococcus epidermidis adherence to intraocular lenses. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201 |
| Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib. | Clinical cancer research : an official journal of the American Association for Cancer Research 20091115 |
| Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies. | Clinical pharmacology and therapeutics 20091101 |
| Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. | The European respiratory journal 20091101 |
| Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection. | International journal of antimicrobial agents 20091101 |
| Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. | International journal of antimicrobial agents 20091101 |
| Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections. | The Journal of antimicrobial chemotherapy 20091101 |
| Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes. | Journal of clinical pharmacology 20091101 |
| Abuse of antibiotic prophylaxis in third molar surgeries. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091101 |
| Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis. | Journal of drugs in dermatology : JDD 20091101 |
| Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines. | Current medical research and opinion 20091001 |
| Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile. | The Journal of hospital infection 20091001 |
| Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091001 |
| Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. | Cornea 20091001 |
| Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis. | Expert opinion on pharmacotherapy 20091001 |
| Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. | Helicobacter 20091001 |
| Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug? | American journal of respiratory and critical care medicine 20091001 |
| Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. | Infection 20091001 |
| One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus. | Journal of cataract and refractive surgery 20091001 |
| A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. | International journal of STD & AIDS 20091001 |
| Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections. | Prescrire international 20091001 |
| Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions. | Prescrire international 20091001 |
| Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC. | Journal of pharmaceutical and biomedical analysis 20090908 |
| Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro. | International journal of antimicrobial agents 20090901 |
| Antibacterial activity of lipophilic fluoroquinolone derivatives. | Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901 |
| Efficacy of fluoroquinolones against pathogenic oral bacteria. | Mini reviews in medicinal chemistry 20090901 |
| Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. | The Journal of antimicrobial chemotherapy 20090901 |
| Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. | Ophthalmology 20090901 |
| Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. | American journal of respiratory and critical care medicine 20090801 |
| Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. | The Journal of antimicrobial chemotherapy 20090801 |
| Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila. | The Journal of antimicrobial chemotherapy 20090801 |
| Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801 |
| Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations. | Journal of clinical pharmacology 20090801 |
| A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects. | Journal of clinical pharmacology 20090801 |
| Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects. | Anesthesia and analgesia 20090801 |
| Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801 |
| Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug. | The American journal of the medical sciences 20090801 |
| 10 years' experience with the pneumococcal quinolone moxifloxacin. | Expert review of anti-infective therapy 20090801 |
| Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20090801 |
| Haemolytic anaemia following rituximab treatment in a patient with pemphigus vulgaris. | The British journal of dermatology 20090701 |
| [Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090701 |
| Moxifloxacin versus ethambutol in initial tuberculosis treatment. | Lancet (London, England) 20090627 |
| Moxifloxacin versus ethambutol in initial tuberculosis treatment. | Lancet (London, England) 20090627 |
| Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. | Veterinary journal (London, England : 1997) 20090601 |
| Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601 |
| Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. | Journal of clinical pharmacology 20090601 |
| Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090601 |
| Late-onset laser in situ keratomileusis-related corneal ulcer--a case series. | Cornea 20090601 |
| Intracameral moxifloxacin: in vitro safety on human ocular cells. | Cornea 20090601 |
| Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. | Nature structural & molecular biology 20090601 |
| Electrocardiographic QTc changes due to moxifloxacin infusion. | Journal of clinical pharmacology 20090601 |
| [A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090601 |
| Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy. | Leprosy review 20090601 |
| Trimethoprim/sulfamethoxazole resistance in urinary tract infections. | The Journal of emergency medicine 20090501 |
| Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. | The Journal of antimicrobial chemotherapy 20090501 |
| Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested. | Journal of clinical pharmacology 20090501 |
| Deferasirox does not induce QT/QTc-prolongation in healthy subjects. | International journal of clinical pharmacology and therapeutics 20090501 |
| Severe and symptomatic hyponatraemia after moxifloxacin intake. | The Netherlands journal of medicine 20090501 |
| Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415 |
| 'My foot hurts': a flare of rheumatoid arthritis? | The Medical journal of Australia 20090406 |
| Fourth-generation fluoroquinolones in tuberculosis. | Lancet (London, England) 20090404 |
| Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. | Lancet (London, England) 20090404 |
| Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin. | International journal of antimicrobial agents 20090401 |
| Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains. | Antimicrobial agents and chemotherapy 20090401 |
| The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. | Free radical research 20090401 |
| Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401 |
| Stability of extemporaneously prepared moxifloxacin oral suspensions. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090401 |
| Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. | Advances in therapy 20090401 |
| Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis. | Journal of chemotherapy (Florence, Italy) 20090401 |
| Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). | Journal of chemotherapy (Florence, Italy) 20090401 |
| Mycobacterium chelonae infection in a tattoo site. | The Medical journal of Australia 20090302 |
| High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy. | The Journal of infection 20090301 |
| Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study. | Journal of clinical pharmacology 20090301 |
| Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones. | Journal of cataract and refractive surgery 20090301 |
| Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. | Xenobiotica; the fate of foreign compounds in biological systems 20090301 |
| Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens. | British poultry science 20090301 |
| Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study. | International journal of antimicrobial agents 20090201 |
| Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. | Therapeutic drug monitoring 20090201 |
| Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. | The Journal of antimicrobial chemotherapy 20090201 |
| Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090201 |
| Fluoroquinolones and postoperative endophthalmitis. | Journal of cataract and refractive surgery 20090201 |
| Fluoroquinolones and postoperative endophthalmitis. | Journal of cataract and refractive surgery 20090201 |
| Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets. | Bosnian journal of basic medical sciences 20090201 |
| Treatment of extensively drug-resistant tuberculosis. | Lancet (London, England) 20090103 |
| Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090101 |
| Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). | International journal of antimicrobial agents 20090101 |
| Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). | International journal of antimicrobial agents 20090101 |
| Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. | Scandinavian journal of infectious diseases 20090101 |
| Cerebrospinal fluid of patients administered moxifloxacin modulates the secretion of cytokines from human monocytes. | Diagnostic microbiology and infectious disease 20090101 |
| Severe pseudomembranous colitis after moxifloxacin use: a case series. | The Annals of pharmacotherapy 20090101 |
| The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. | Cornea 20090101 |
| Automated QT measurement and application to detection of moxifloxacin-induced changes. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101 |
| ECG evaluation of ventricular properties: the importance of cardiac cycle length. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101 |
| Automated QT analysis that learns from cardiologist annotations. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101 |
| Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. | Wiener klinische Wochenschrift 20090101 |
| Acute generalized exanthematous pustulosis following oral treatment with moxifloxacine. | European journal of dermatology : EJD 20090101 |
| Aspergillus iris granuloma: a case report with review of literature. | Survey of ophthalmology 20090101 |
| Penetration of moxifloxacin into rat mandibular bone and soft tissue. | Acta odontologica Scandinavica 20090101 |
| Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling. | Clinical pharmacokinetics 20090101 |
| Extensively drug resistance (XDR) tb is not always fatal. | The Indian journal of tuberculosis 20090101 |
| Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. | Drug safety 20090101 |
| Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing. | Journal of pharmacological and toxicological methods 20090101 |
| [Conjunctivitis due to Achromobacter xylosoxidans: case report]. | Arquivos brasileiros de oftalmologia 20090101 |
| Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. | Ophthalmic research 20090101 |
| [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101 |
| The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. | American journal of therapeutics 20090101 |
| [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo]. | Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20090101 |
| Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101 |
| Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis. | Heart & lung : the journal of critical care 20090101 |
| Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis. | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101 |
| Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials. | Internal medicine (Tokyo, Japan) 20090101 |
| [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101 |
| Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. | Digestive diseases and sciences 20081201 |
| In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan). | International journal of antimicrobial agents 20081201 |
| Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes. | Acta pharmacologica Sinica 20081201 |
| A comparison of fluoroquinolone penetration into human conjunctival tissue. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201 |
| Extensively drug-resistant tuberculosis. | The New England journal of medicine 20081127 |
| Disposition kinetics of moxifloxacin in lactating ewes. | Veterinary journal (London, England : 1997) 20081101 |
| Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine. | Clinical pharmacology and therapeutics 20081101 |
| Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. | Biomedical chromatography : BMC 20081101 |
| [Severe febrile illness with renal impairment after travel to Southeast Asia]. | Der Internist 20081101 |
| Disseminated salmonellosis in a patient treated with temozolomide. | The Journal of infection 20081101 |
| Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis? | American journal of respiratory and critical care medicine 20081101 |
| Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells. | Current eye research 20081101 |
| Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. | Clinical therapeutics 20081101 |
| Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel. | Journal of the American Chemical Society 20081008 |
| Eikenella corrodens as a causative agent for neonatal conjunctivitis. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20081001 |
| Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20081001 |
| Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001 |
| Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. | International journal of STD & AIDS 20081001 |
| Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. | Journal of periodontology 20081001 |
| Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. | Advances in therapy 20081001 |
| The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. | Clinical pharmacology and therapeutics 20081001 |
| Moxifloxacin monotherapy in severe pneumonia: do we really need it? | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080915 |
| Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080901 |
| Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment. | The Journal of antimicrobial chemotherapy 20080901 |
| Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. | The Journal of antimicrobial chemotherapy 20080901 |
| Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. | British journal of clinical pharmacology 20080901 |
| Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin. | International journal of clinical practice 20080901 |
| Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. | Journal of cataract and refractive surgery 20080901 |
| Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. | Journal of cataract and refractive surgery 20080901 |
| Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. | Cornea 20080901 |
| Biofilm formation is not necessary for development of quinolone-resistant 'persister' cells in an attached Staphylococcus epidermidis population. | The International journal of artificial organs 20080901 |
| [Novel side effects of moxifloxacin: making a balanced decision again]. | Nederlands tijdschrift voor geneeskunde 20080823 |
| Penetration and accumulation of moxifloxacin in uterine tissue. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080801 |
| Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK? | International journal of antimicrobial agents 20080801 |
| A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment. | Contact lens & anterior eye : the journal of the British Contact Lens Association 20080801 |
| Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability. | British journal of pharmacology 20080801 |
| Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin. | Journal of cataract and refractive surgery 20080801 |
| Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora. | Journal of cataract and refractive surgery 20080801 |
| Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801 |
| Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis. | Journal of drugs in dermatology : JDD 20080801 |
| Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080801 |
| Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece. | The Journal of antimicrobial chemotherapy 20080701 |
| Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects. | Journal of clinical pharmacology 20080701 |
| In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa. | International journal of antimicrobial agents 20080701 |
| Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. | The Journal of infection 20080701 |
| A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin. | Expert opinion on pharmacotherapy 20080701 |
| Moxifloxacin: a respiratory fluoroquinolone. | Expert opinion on pharmacotherapy 20080701 |
| Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. | Journal of cataract and refractive surgery 20080701 |
| Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. | International journal of surgical pathology 20080701 |
| A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve. | Heart and vessels 20080701 |
| Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. | The Journal of antimicrobial chemotherapy 20080601 |
| Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval. | Journal of clinical pharmacology 20080601 |
| Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers. | The Annals of pharmacotherapy 20080601 |
| Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. | The British journal of ophthalmology 20080601 |
| Moxifloxacin for bacterial keratitis. | Ophthalmology 20080601 |
| [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci]. | Biomedica : revista del Instituto Nacional de Salud 20080601 |
| In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. | World journal of gastroenterology 20080528 |
| Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515 |
| Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines. | Diagnostic microbiology and infectious disease 20080501 |
| A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. | Current medical research and opinion 20080501 |
| Interactions between warfarin and three commonly prescribed fluoroquinolones. | The Annals of pharmacotherapy 20080501 |
| Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin. | Southern medical journal 20080501 |
| Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin. | Acta neurochirurgica 20080501 |
| Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery. | Journal of cataract and refractive surgery 20080501 |
| Minimising moxifloxacin resistance with tuberculosis. | The Lancet. Infectious diseases 20080501 |
| Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells. | Clinical & experimental ophthalmology 20080501 |
| Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach. | Biophysical journal 20080415 |
| Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects. | British journal of clinical pharmacology 20080401 |
| Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis. | The Annals of pharmacotherapy 20080401 |
| Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus. | Journal of medical microbiology 20080401 |
| Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty. | Cornea 20080401 |
| Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080325 |
| Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects. | Biochemical pharmacology 20080315 |
| Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure. | Diagnostic microbiology and infectious disease 20080301 |
| Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis. A case report and review of literature. | The Knee 20080301 |
| Does in vitro susceptibility predict clinical outcome in bacterial keratitis? | American journal of ophthalmology 20080301 |
| A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium. | Current medical research and opinion 20080301 |
| Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis. | The Journal of antimicrobial chemotherapy 20080301 |
| In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. | Journal of cataract and refractive surgery 20080301 |
| Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea. | Optometry (St. Louis, Mo.) 20080301 |
| In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin. | Eye & contact lens 20080301 |
| Vitreal penetration of oral moxifloxacin in humans. | Retina (Philadelphia, Pa.) 20080301 |
| A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. | Current medical research and opinion 20080301 |
| Moxifloxacin. | Tuberculosis (Edinburgh, Scotland) 20080301 |
| Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080201 |
| In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant. | Diagnostic microbiology and infectious disease 20080201 |
| Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. | Anaerobe 20080201 |
| Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin. | The Journal of infection 20080201 |
| Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. | International journal of antimicrobial agents 20080201 |
| Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells. | Current medical research and opinion 20080201 |
| One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. | Helicobacter 20080201 |
| Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis. | Cornea 20080201 |
| A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080201 |
| Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. | Infection 20080201 |
| Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. | Journal of cataract and refractive surgery 20080201 |
| Endophthalmitis. | Ophthalmology 20080201 |
| Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080201 |
| Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. | Clinical therapeutics 20080201 |
| Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results? | Journal of chemotherapy (Florence, Italy) 20080201 |
| Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis. | Journal of chemotherapy (Florence, Italy) 20080201 |
| Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201 |
| Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies. | Clinical pharmacology and therapeutics 20080101 |
| Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D. | The Journal of antimicrobial chemotherapy 20080101 |
| Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers. | International journal of antimicrobial agents 20080101 |
| Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver. | The Journal of pharmacy and pharmacology 20080101 |
| Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation. | Drug safety 20080101 |
| Promising results for new tuberculosis therapy. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080101 |
| Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080101 |
| Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. | Eye & contact lens 20080101 |
| Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries. | Respirology (Carlton, Vic.) 20080101 |
| Primary photophysical properties of moxifloxacin--a fluoroquinolone antibiotic. | Photochemistry and photobiology 20080101 |
| Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess. | Clinical drug investigation 20080101 |
| Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis. | Ophthalmic research 20080101 |
| Early bacterial keratitis after presbyopic LASIK. | Cornea 20080101 |
| Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. | Drug safety 20080101 |
| Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis. | Journal of investigational allergology & clinical immunology 20080101 |
| A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies. | Journal of biopharmaceutical statistics 20080101 |
| Validation testing in thorough QT/QTc clinical trials. | Journal of biopharmaceutical statistics 20080101 |
| Statistical issues of QT prolongation assessment based on linear concentration modeling. | Journal of biopharmaceutical statistics 20080101 |
| Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. | PloS one 20080101 |
| Fluoroquinolone resistance during 2000-2005: an observational study. | BMC infectious diseases 20080101 |
| Severe acute polyarthritis in a child after high doses of moxifloxacin. | Scandinavian journal of infectious diseases 20080101 |
| Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland. | Polish journal of microbiology 20080101 |
| Moxifloxacin-induced torsades de pointes. | Cardiology journal 20080101 |
| A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model. | Japanese journal of ophthalmology 20080101 |
| Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration. | Retina (Philadelphia, Pa.) 20080101 |
| [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases]. | Annales de dermatologie et de venereologie 20080101 |
| Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis. | Journal of pediatric ophthalmology and strabismus 20080101 |
| A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. | Journal of pediatric ophthalmology and strabismus 20080101 |
| The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy. | Veterinary ophthalmology 20080101 |
| [Unwanted side effects of antibacterials--a diagnostic challenge]. | Deutsche medizinische Wochenschrift (1946) 20080101 |
| Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. | International journal of pharmaceutics 20071210 |
| The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction. | British journal of clinical pharmacology 20071201 |
| Ocular cysticercosis of the anterior segment. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20071201 |
| Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). | Rheumatology (Oxford, England) 20071201 |
| Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial. | Current medical research and opinion 20071201 |
| Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. | Journal of veterinary pharmacology and therapeutics 20071201 |
| Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide. | Peptides 20071201 |
| Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201 |
| Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. | Helicobacter 20071201 |
| A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. | Infection 20071201 |
| Nosocomial pneumonia - are economical considerations important? | Infection 20071201 |
| Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus. | Cornea 20071201 |
| Electroconvulsive therapy and antibiotics: a case report. | The journal of ECT 20071201 |
| Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model. | PLoS medicine 20071201 |
| Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis. | Clinical therapeutics 20071201 |
| Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty. | Journal of chemotherapy (Florence, Italy) 20071201 |
| Ototoxicity of topical moxifloxacin in a chinchilla animal model. | The Laryngoscope 20071201 |
| Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans. | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071201 |
| Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. | International journal of antimicrobial agents 20071101 |
| In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. | The Journal of antimicrobial chemotherapy 20071101 |
| Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. | European journal of clinical pharmacology 20071101 |
| [In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci]. | Pathologie-biologie 20071101 |
| The increasing problem of antibiotic resistance. | Journal of cataract and refractive surgery 20071101 |
| Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. | Journal of cataract and refractive surgery 20071101 |
| In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas. | Die Pharmazie 20071101 |
| Doctors report breakthrough antibiotic treatment for TB. | The AIDS reader 20071101 |
| Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives. | Bioorganic & medicinal chemistry letters 20071015 |
| Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071015 |
| Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071001 |
| Emergency department drug orders: does drug storage location make a difference? | Annals of emergency medicine 20071001 |
| Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population. | Helicobacter 20071001 |
| Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. | Oral microbiology and immunology 20071001 |
| Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis. | Journal of veterinary pharmacology and therapeutics 20071001 |
| Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. | Journal of cataract and refractive surgery 20071001 |
| Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071001 |
| Drug combo speeds up TB treatment. | AIDS patient care and STDs 20071001 |
| Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20071001 |
| [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin]. | Der Urologe. Ausg. A 20070901 |
| Vitreous and aqueous penetration of orally administered moxifloxacin in humans. | Eye (London, England) 20070901 |
| Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China. | International journal of clinical practice 20070901 |
| Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis. | Current medical research and opinion 20070901 |
| Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. | Ophthalmology 20070901 |
| Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event. | The Canadian journal of cardiology 20070901 |
| Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD. | International journal of chronic obstructive pulmonary disease 20070901 |
| Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom. | Ophthalmology 20070801 |
| Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. | The Journal of antimicrobial chemotherapy 20070801 |
| Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus. | Antimicrobial agents and chemotherapy 20070801 |
| Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy. | American journal of ophthalmology 20070801 |
| Fourth-generation fluoroquinolone-resistant bacterial keratitis. | Journal of cataract and refractive surgery 20070801 |
| [Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany]. | Infection 20070801 |
| Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. | Eye (London, England) 20070701 |
| Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers. | Diagnostic microbiology and infectious disease 20070701 |
| Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro. | Cornea 20070701 |
| [Brochiectasis (in the adult)]. | Praxis 20070613 |
| Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. | Journal of cardiovascular electrophysiology 20070601 |
| Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model. | Cornea 20070601 |
| Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. | Cornea 20070601 |
| The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. | Current medical research and opinion 20070601 |
| Nocardia farcinica brain abscess in a patient without immunocompromise. | British journal of neurosurgery 20070601 |
| A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). | Clinical interventions in aging 20070601 |
| In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. | Ophthalmology 20070501 |
| In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces. | Journal of endodontics 20070501 |
| Central venous catheter-related Streptomyces septic thrombosis. | Infection control and hospital epidemiology 20070501 |
| Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae. | Eye & contact lens 20070501 |
| [Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070501 |
| The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy. | The journal of physical chemistry. A 20070419 |
| Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. | Diabetes research and clinical practice 20070401 |
| Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. | Ophthalmology 20070401 |
| Arrhythmias associated with fluoroquinolone therapy. | International journal of antimicrobial agents 20070401 |
| Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070401 |
| Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus. | The Journal of antimicrobial chemotherapy 20070401 |
| Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus. | Journal of chemotherapy (Florence, Italy) 20070401 |
| Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. | Current eye research 20070401 |
| The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy. | Journal of refractive surgery (Thorofare, N.J. : 1995) 20070401 |
| Treatment of ankylosing spondylitis with moxifloxacin. | Southern medical journal 20070401 |
| Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates. | European journal of medical research 20070326 |
| Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. | Veterinary journal (London, England : 1997) 20070301 |
| Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose. | Journal of cataract and refractive surgery 20070301 |
| Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin. | Diagnostic microbiology and infectious disease 20070301 |
| Thorough QT study with recommended and supratherapeutic doses of tolterodine. | Clinical pharmacology and therapeutics 20070301 |
| QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study. | Journal of cardiovascular pharmacology 20070301 |
| Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. | Antimicrobial agents and chemotherapy 20070201 |
| Influence of structural factors on the enhanced activity of moxifloxacin: a fluorescence and EPR spectroscopic study. | Analytical and bioanalytical chemistry 20070201 |
| parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones. | International journal of antimicrobial agents 20070201 |
| In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. | Cornea 20070201 |
| A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment. | Cornea 20070201 |
| Vitreal penetration of oral and topical moxifloxacin in humans. | American journal of ophthalmology 20070201 |
| Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. | Infection control and hospital epidemiology 20070201 |
| Dysglycemia and fluoroquinolones: are you putting patients at risk? | The Journal of family practice 20070201 |
| Moxifloxacin and torsade de pointes. | The Annals of pharmacotherapy 20070201 |
| Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects. | Journal of chemotherapy (Florence, Italy) 20070201 |
| [In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae]. | Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20070201 |
| Pneumopericardium masquerading as an acute myocardial infarction. | International journal of cardiology 20070118 |
| Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin. | Analytica chimica acta 20070116 |
| High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma. | Journal of pharmaceutical and biomedical analysis 20070104 |
| Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. | American journal of physiology. Lung cellular and molecular physiology 20070101 |
| Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. | The Journal of antimicrobial chemotherapy 20070101 |
| Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin. | Journal of pharmacological and toxicological methods 20070101 |
| Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones. | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101 |
| Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. | International journal of antimicrobial agents 20070101 |
| Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. | Journal of cataract and refractive surgery 20070101 |
| Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. | Journal of cataract and refractive surgery 20070101 |
| Moxifloxacin-induced arthropathy. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20070101 |
| Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting. | Clinical drug investigation 20070101 |
| [Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis]. | Archivos de bronconeumologia 20070101 |
| Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus. | Drugs in R&D 20070101 |
| Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. | American journal of otolaryngology 20070101 |
| Methicillin-resistant Staphylococcus aureus caruncle abscess. | Ophthalmic plastic and reconstructive surgery 20070101 |
| Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. | American journal of rhinology 20070101 |
| [Nongonococcal urethritis treatment in men with avelox (moxifloxacin)]. | Urologiia (Moscow, Russia : 1999) 20070101 |
| Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae. | Wiener klinische Wochenschrift 20070101 |
| Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection. | Arquivos brasileiros de oftalmologia 20070101 |
| High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. | Wiener klinische Wochenschrift 20070101 |
| A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499. | Journal of pharmacological and toxicological methods 20070101 |
| Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. | Journal of pharmacological and toxicological methods 20070101 |
| [Avelox efficacy in the treatment of acute purulent rhinosinusitis]. | Terapevticheskii arkhiv 20070101 |
| [Pulmonary fibrosis induced by amiodarone--a pitfall of antiarrhytmic treatment]. | Pneumologia (Bucharest, Romania) 20070101 |
| Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies. | Advances in therapy 20070101 |
| The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome. | The Journal of international medical research 20070101 |
| Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report. | Journal of medical case reports 20070101 |
| [Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes]. | Medycyna doswiadczalna i mikrobiologia 20070101 |
| [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101 |
| Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. | Sexually transmitted infections 20061201 |
| High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. | The Journal of antimicrobial chemotherapy 20061201 |
| In vitro development of resistance to DX-619 and other quinolones in enterococci. | The Journal of antimicrobial chemotherapy 20061201 |
| No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block. | British journal of pharmacology 20061201 |
| Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty. | Journal of cataract and refractive surgery 20061201 |
| Stability indicating methods for the determination of some fluoroquinolones in the presence of their decarboxylated degrades. | Chemical & pharmaceutical bulletin 20061201 |
| Evaluation of the penetration of fluoroquinolones in human conjunctival tissue. | Archives of ophthalmology (Chicago, Ill. : 1960) 20061201 |
| In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. | Ocular immunology and inflammation 20061201 |
| Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%). | Journal of clinical pharmacy and therapeutics 20061201 |
| Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies. | Clinical cardiology 20061201 |
| [Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration]. | Enfermedades infecciosas y microbiologia clinica 20061201 |
| Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis. | Journal of chemotherapy (Florence, Italy) 20061201 |
| The first steps towards fluoroquinolone resistance in Hungarian pneumococci. | Journal of chemotherapy (Florence, Italy) 20061201 |
| Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061121 |
| Vitreous and aqueous penetration of orally administered moxifloxacin in humans. | Eye (London, England) 20061101 |
| Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. | The Journal of antimicrobial chemotherapy 20061101 |
| Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. | The Journal of antimicrobial chemotherapy 20061101 |
| The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy. | American journal of ophthalmology 20061101 |
| Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. | American journal of ophthalmology 20061101 |
| Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery. | International journal of antimicrobial agents 20061101 |
| Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. | Clinical journal of the American Society of Nephrology : CJASN 20061101 |
| Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells. | British journal of cancer 20061023 |
| Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. | Respiratory medicine 20061001 |
| Moxifloxacin prophylaxis in neutropenic patients. | The Journal of antimicrobial chemotherapy 20061001 |
| Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones. | Journal of cataract and refractive surgery 20061001 |
| The effect of moxifloxacin on the normal human cornea. | Current medical research and opinion 20061001 |
| [Cardiac tolerance of moxifloxacin: Clinical experience from a large observational French study in usual medical practice (IMMEDIAT study)]. | Medecine et maladies infectieuses 20061001 |
| Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate. | Journal of chemotherapy (Florence, Italy) 20061001 |
| Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue. | Cornea 20061001 |
| Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty. | Cornea 20061001 |
| Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. | Veterinary journal (London, England : 1997) 20060901 |
| Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. | Respiratory medicine 20060901 |
| Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort. | Respiratory medicine 20060901 |
| The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20060901 |
| Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20060901 |
| Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis. | The Journal of antimicrobial chemotherapy 20060901 |
| Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study. | International journal of antimicrobial agents 20060901 |
| Intracranial Nocardia recurrence during fluorinated quinolones therapy. | Transplant infectious disease : an official journal of the Transplantation Society 20060901 |
| Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060901 |
| Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections. | Eye & contact lens 20060901 |
| Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. | American journal of respiratory and critical care medicine 20060801 |
| A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. | The Journal of antimicrobial chemotherapy 20060801 |
| Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. | Annals of surgery 20060801 |
| Permeability of pig urinary bladder wall: time and concentration dependent effect of chitosan. | Biological & pharmaceutical bulletin 20060801 |
| Moxifloxacinium chloride-water-methanol (2/1/1), a novel antibacterial agent. | Acta crystallographica. Section C, Crystal structure communications 20060801 |
| Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment. | Infection 20060801 |
| In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060801 |
| Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration. | Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20060801 |
| Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801 |
| Application of two methods to determine killing of Streptococcus pneumoniae by various fluoroquinolones. | Journal of chemotherapy (Florence, Italy) 20060801 |
| Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20060801 |
| Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases. | Cornea 20060801 |
| Potent twice-weekly rifapentine-containing regimens in murine tuberculosis. | American journal of respiratory and critical care medicine 20060701 |
| Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. | The Journal of pharmacology and experimental therapeutics 20060701 |
| Treatment of hospitalized patients with community-acquired pneumonia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701 |
| Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701 |
| Azithromycin failure in Mycoplasma genitalium urethritis. | Emerging infectious diseases 20060701 |
| Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea. | Eye & contact lens 20060701 |
| Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. | Journal of pharmaceutical and biomedical analysis 20060616 |
| Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. | Ophthalmology 20060601 |
| Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection. | Analytical biochemistry 20060601 |
| Man versus machine: is there an optimal method for QT measurements in thorough QT studies? | Journal of clinical pharmacology 20060601 |
| Controversies in antibiotic choices for odontogenic infections. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060601 |
| Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20060601 |
| Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. | The Journal of antimicrobial chemotherapy 20060501 |
| [Pathogenesis, diagnosis and therapy of Legionella infections]. | Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. | International journal of antimicrobial agents 20060501 |
| Treatment of implant-associated infections with moxifloxacin: an animal study. | International journal of antimicrobial agents 20060501 |
| Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501 |
| Phakic status affects vitreous penetration of topical moxifloxacin. | Archives of ophthalmology (Chicago, Ill. : 1960) 20060501 |
| Vigamox: how good is its self-preservation? | Journal of cataract and refractive surgery 20060501 |
| First successful treatment of Nocardia farcinica brain abscess with moxifloxacin. | The Journal of infection 20060401 |
| Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin. | British journal of pharmacology 20060401 |
| Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. | The Journal of antimicrobial chemotherapy 20060401 |
| Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones. | International journal of antimicrobial agents 20060401 |
| Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model. | American journal of ophthalmology 20060401 |
| Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. | Investigative ophthalmology & visual science 20060401 |
| Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection. | Journal of chromatographic science 20060401 |
| Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study. | Journal of cataract and refractive surgery 20060401 |
| Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats. | Acta orthopaedica 20060401 |
| Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method. | International journal of pharmaceutics 20060327 |
| Glucose homeostasis abnormalities and gatifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060315 |
| Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. | AAPS PharmSciTech 20060301 |
| Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. | Journal of cataract and refractive surgery 20060301 |
| Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. | The Journal of antimicrobial chemotherapy 20060201 |
| Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields. | Cornea 20060201 |
| Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. | Helicobacter 20060201 |
| Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. | Current medical research and opinion 20060201 |
| Intravitreal toxicity of moxifloxacin. | Retina (Philadelphia, Pa.) 20060201 |
| Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. | Retina (Philadelphia, Pa.) 20060201 |
| Vitreous and aqueous penetration of orally administered moxifloxacin in humans. | Archives of ophthalmology (Chicago, Ill. : 1960) 20060201 |
| [Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update]. | Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20060201 |
| [Cervical spondylodiscitis: one pathogen may hide another]. | Medecine et maladies infectieuses 20060101 |
| Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101 |
| [Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004]. | Medecine et maladies infectieuses 20060101 |
| Clearance of intravitreal moxifloxacin. | Investigative ophthalmology & visual science 20060101 |
| T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20060101 |
| Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. | Current eye research 20060101 |
| Effects of three fluoroquinolones on QT analysis after standard treatment courses. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101 |
| The pediatrician's dilemma. | Journal of pediatric ophthalmology and strabismus 20060101 |
| Controlling contagious bacterial conjunctivitis. | Journal of pediatric ophthalmology and strabismus 20060101 |
| Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis. | Clinical pharmacokinetics 20060101 |
| Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. | Microbial drug resistance (Larchmont, N.Y.) 20060101 |
| Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation. | Journal of pharmacological and toxicological methods 20060101 |
| Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods. | Chemotherapy 20060101 |
| A preoperative mixture of anesthetic jelly, dilating drops, antibiotics, and anti-inflammatories for cataract surgery. | Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20060101 |
| In vitro activity of fluoroquinolones against common respiratory pathogens. | The West Indian medical journal 20060101 |
| Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. | Survey of ophthalmology 20060101 |
| Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis. | Scandinavian journal of infectious diseases 20060101 |
| Evidence-based review of moxifloxacin. | International ophthalmology clinics 20060101 |
| Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101 |
| Efficacy and tolerability of moxifloxacin in patients with respiratory tract infections treated in general practice: Results of a post-marketing surveillance study. | Clinical drug investigation 20060101 |
| Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice. | Clinical drug investigation 20060101 |
| [Efficacy of moxifloxacin in the treatment of secondary peritonitis]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101 |
| Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101 |
| [Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101 |
| [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101 |
| Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215 |
| Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis. | American journal of respiratory and critical care medicine 20051201 |
| Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model. | American journal of respiratory and critical care medicine 20051201 |
| Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis. | The Journal of antimicrobial chemotherapy 20051201 |
| Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. | The Journal of antimicrobial chemotherapy 20051201 |
| In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice. | The Journal of antimicrobial chemotherapy 20051201 |
| Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice. | The Journal of antimicrobial chemotherapy 20051201 |
| Hopkins scientist tunes in to treat tuberculosis. | The Journal of clinical investigation 20051201 |
| Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20051201 |
| Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations. | Infection 20051201 |
| The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. | Infection 20051201 |
| Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model. | Infection 20051201 |
| Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro. | Infection 20051201 |
| Intravitreal clearance of moxifloxacin. | Transactions of the American Ophthalmological Society 20051201 |
| QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome. | British journal of pharmacology 20051101 |
| Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. | The Journal of antimicrobial chemotherapy 20051101 |
| Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. | Ophthalmology 20051101 |
| Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. | The Journal of antimicrobial chemotherapy 20051101 |
| Glucose homeostasis abnormalities associated with use of gatifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101 |
| Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. | International journal of antimicrobial agents 20051101 |
| Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. | Cornea 20051101 |
| Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection. | International journal of antimicrobial agents 20051101 |
| Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia. | International journal of clinical practice 20051101 |
| Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). | Diagnostic microbiology and infectious disease 20051101 |
| Ophthalmic infections and their anti-infective challenges. | Survey of ophthalmology 20051101 |
| In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. | Survey of ophthalmology 20051101 |
| Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. | Survey of ophthalmology 20051101 |
| Safety of moxifloxacin as shown in animal and in vitro studies. | Survey of ophthalmology 20051101 |
| Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis. | Survey of ophthalmology 20051101 |
| Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). | Survey of ophthalmology 20051101 |
| Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). | Survey of ophthalmology 20051101 |
| Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? | The American journal of tropical medicine and hygiene 20051101 |
| A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. | Chest 20051101 |
| Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. | Journal of cataract and refractive surgery 20051101 |
| Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. | Journal of cataract and refractive surgery 20051101 |
| The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty. | Cornea 20051001 |
| Cost analyses of community-acquired pneumonia from the hospital perspective. | Chest 20051001 |
| Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation. | Journal of cataract and refractive surgery 20051001 |
| [The basic and clinical studies of moxifloxacin: the profile as respiratory quinolones]. | The Japanese journal of antibiotics 20051001 |
| In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. | The Medical journal of Malaysia 20051001 |
| Differential effects of three antibiotics on T helper cell cytokine expression. | The Journal of antimicrobial chemotherapy 20050901 |
| Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901 |
| Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. | American journal of ophthalmology 20050901 |
| The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050901 |
| Empirical antimicrobial therapy for odontogenic infections. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050901 |
| Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract. | Alimentary pharmacology & therapeutics 20050901 |
| Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. | Archives of ophthalmology (Chicago, Ill. : 1960) 20050901 |
| In-use study of potential bacterial contamination of ophthalmic moxifloxacin. | Journal of cataract and refractive surgery 20050901 |
| Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. | Respiratory medicine 20050801 |
| Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro. | The Journal of antimicrobial chemotherapy 20050801 |
| Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures. | Journal of medical microbiology 20050801 |
| Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. | Journal of veterinary pharmacology and therapeutics 20050801 |
| Influence of human ascitic fluid on the in vitro antibacterial activity of moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20050801 |
| Acute interstitial nephritis associated with moxifloxacin use. | Clinical therapeutics 20050801 |
| Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715 |
| Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715 |
| Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715 |
| Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715 |
| Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model. | The Journal of antimicrobial chemotherapy 20050701 |
| Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. | The Journal of antimicrobial chemotherapy 20050701 |
| The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. | American journal of ophthalmology 20050701 |
| Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. | Cancer 20050615 |
| Prophylactic use of moxifloxacin in patients receiving bone marrow transplants was not associated with increased ciprofloxacin resistance in Escherichia coli and enterococci. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050615 |
| Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20050601 |
| In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii. | The Journal of antimicrobial chemotherapy 20050601 |
| A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates. | International journal of antimicrobial agents 20050601 |
| Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells. | The Journal of urology 20050601 |
| Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. | International journal of antimicrobial agents 20050601 |
| Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis. | Journal of pharmaceutical and biomedical analysis 20050601 |
| Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction. | Pharmacotherapy 20050601 |
| Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050601 |
| Effects of moxifloxacin on QT interval in conscious dogs. | Journal of veterinary pharmacology and therapeutics 20050601 |
| A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050601 |
| [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050601 |
| Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20050515 |
| Vibrational spectroscopic characterization of fluoroquinolones. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501 |
| Penetration of moxifloxacin into the human aqueous humour after oral administration. | The British journal of ophthalmology 20050501 |
| Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males. | British journal of clinical pharmacology 20050501 |
| Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501 |
| The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae. | Critical care medicine 20050501 |
| Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. | The Journal of antimicrobial chemotherapy 20050401 |
| Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection. | The Journal of antimicrobial chemotherapy 20050401 |
| Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval. | Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20050401 |
| Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050401 |
| Clinical assessment of drug-induced QT prolongation in association with heart rate changes. | Clinical pharmacology and therapeutics 20050401 |
| In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. | Journal of chemotherapy (Florence, Italy) 20050401 |
| In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. | Journal of chemotherapy (Florence, Italy) 20050401 |
| Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line. | The Journal of antimicrobial chemotherapy 20050301 |
| Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. | The Tohoku journal of experimental medicine 20050301 |
| Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. | Cornea 20050301 |
| Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. | Ophthalmology 20050301 |
| [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. | Enfermedades infecciosas y microbiologia clinica 20050301 |
| Protonation equilibrium and lipophilicity of moxifloxacin. | Journal of pharmaceutical and biomedical analysis 20050223 |
| Moxifloxacin-warfarin interaction: a series of five case reports. | The Annals of pharmacotherapy 20050201 |
| In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point. | International journal of antimicrobial agents 20050201 |
| [Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050201 |
| Moxifloxacin in respiratory tract infections. | Expert opinion on pharmacotherapy 20050201 |
| Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. | The Journal of antimicrobial chemotherapy 20050101 |
| Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols. | Cornea 20050101 |
| Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. | Archives of ophthalmology (Chicago, Ill. : 1960) 20050101 |
| [Tendinitis in the Achilles in the elderly]. | Atencion primaria 20050101 |
| Tolerability of moxifloxacin in patients with antibiotic hypersensitivity. | Allergologia et immunopathologia 20050101 |
| Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials. | Drug safety 20050101 |
| Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. | Current medical research and opinion 20050101 |
| [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains]. | Problemy tuberkuleza i boleznei legkikh 20050101 |
| Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis. | Heart & lung : the journal of critical care 20050101 |
| Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. | Journal of investigational allergology & clinical immunology 20050101 |
| Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers. | Clinical pharmacokinetics 20050101 |
| Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model. | Arzneimittel-Forschung 20050101 |
| Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets. | Journal of AOAC International 20050101 |
| Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis. | Neurocritical care 20050101 |
| [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico]. | Gaceta medica de Mexico 20050101 |
| Cure of Q fever pneumonia with moxifloxacin: case report. | Scandinavian journal of infectious diseases 20050101 |
| [Efficacy of moxifloxacin in the treatment of respiratory tract infections: the Croatian post-marketing study]. | Lijecnicki vjesnik 20050101 |
| [Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20050101 |
| Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. | The Journal of antimicrobial chemotherapy 20041201 |
| Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. | Archives of dermatology 20041201 |
| Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. | Transactions of the American Ophthalmological Society 20041201 |
| Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. | American journal of respiratory and critical care medicine 20041115 |
| [Antibiotic therapy of respiratory tract infections. Rapid and good effectiveness]. | MMW Fortschritte der Medizin 20041111 |
| [Moxifloxacin in general practice. Economical concept]. | MMW Fortschritte der Medizin 20041111 |
| Impact of plasma protein binding on antimicrobial activity using time-killing curves. | The Journal of antimicrobial chemotherapy 20041101 |
| Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. | The Journal of infection 20041101 |
| Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. | The Journal of infectious diseases 20041101 |
| Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. | The Journal of emergency medicine 20041101 |
| Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis. | Chemotherapy 20041101 |
| A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability. | Current medical research and opinion 20041101 |
| MOSAIC acronym. | Chest 20041101 |
| [Role of moxifloxacin in the treatment of community-acquired pneumonia]. | Orvosi hetilap 20041031 |
| [After stroke threatens pneumonia. Antibiotics to be given prophylactically?]. | MMW Fortschritte der Medizin 20041028 |
| [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin]. | Nederlands tijdschrift voor geneeskunde 20041023 |
| Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015 |
| Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits. | The Journal of infectious diseases 20041015 |
| In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. | Oral microbiology and immunology 20041001 |
| Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration. | The Journal of antimicrobial chemotherapy 20041001 |
| Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials. | International journal of antimicrobial agents 20041001 |
| Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. | Journal of cataract and refractive surgery 20041001 |
| The effect of cataract surgery on ocular levels of topical moxifloxacin. | American journal of ophthalmology 20041001 |
| Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. | Journal of periodontology 20041001 |
| Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. | International journal of clinical practice 20041001 |
| Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041001 |
| In vitro activity of moxifloxacin against community respiratory pathogens in Qatar. | International journal of antimicrobial agents 20040901 |
| SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease. | Antimicrobial agents and chemotherapy 20040901 |
| Penetration of newer quinolones in the empyema fluid. | The European respiratory journal 20040901 |
| What is a MOSAIC study? | Chest 20040901 |
| Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20040901 |
| In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. | The Journal of antimicrobial chemotherapy 20040801 |
| Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. | Current opinion in ophthalmology 20040801 |
| Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers. | International journal of antimicrobial agents 20040801 |
| Moxifloxacin--a new fluoroquinolone antibacterial. | Drug and therapeutics bulletin 20040801 |
| Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including resistant and multidrug-resistant strains. | Journal of chemotherapy (Florence, Italy) 20040801 |
| Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. | Annals of hematology 20040701 |
| Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones. | The Journal of antimicrobial chemotherapy 20040701 |
| Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria. | The Journal of antimicrobial chemotherapy 20040701 |
| Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects. | Journal of clinical pharmacology 20040701 |
| Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. | American journal of ophthalmology 20040701 |
| [Acute and bilateral uveitis secondary to moxifloxacin]. | Archivos de la Sociedad Espanola de Oftalmologia 20040701 |
| Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies. | Clinical therapeutics 20040701 |
| Evaluation of vardenafil and sildenafil on cardiac repolarization. | The American journal of cardiology 20040601 |
| New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents. | International journal of antimicrobial agents 20040601 |
| Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice. | Chemotherapy 20040601 |
| Moxifloxacin and biofilm production by coagulase-negative staphylococci. | Chemotherapy 20040601 |
| Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040515 |
| Clinical experience with moxifloxacin in patients with respiratory tract infections. | The Annals of pharmacotherapy 20040501 |
| Moxifloxacin penetration into human gastrointestinal tissues. | The Journal of antimicrobial chemotherapy 20040501 |
| Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. | Journal of clinical periodontology 20040501 |
| Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. | International journal of antimicrobial agents 20040501 |
| Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. | Current eye research 20040501 |
| Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin. | Chemistry & biodiversity 20040501 |
| Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040401 |
| Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens. | Diagnostic microbiology and infectious disease 20040401 |
| Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. | Chemotherapy 20040401 |
| Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar). | The Medical letter on drugs and therapeutics 20040329 |
| Structural identification and characterization of impurities in moxifloxacin. | Journal of pharmaceutical and biomedical analysis 20040310 |
| [Gigantic study planned. 100,000 patients with COPD test general practice antibiotic]. | MMW Fortschritte der Medizin 20040304 |
| Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma. | Analytical and bioanalytical chemistry 20040301 |
| Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study. | Antimicrobial agents and chemotherapy 20040301 |
| No more equivalence trials for antibiotics in exacerbations of COPD, please. | Chest 20040301 |
| Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. | Chest 20040301 |
| Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. | Chest 20040301 |
| Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method. | Diagnostic microbiology and infectious disease 20040301 |
| Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. | Survey of ophthalmology 20040301 |
| In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome. | European journal of pharmacology 20040220 |
| Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. | American journal of respiratory and critical care medicine 20040201 |
| Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. | The Journal of antimicrobial chemotherapy 20040201 |
| Pharmacologic considerations for cataract surgery. | Current opinion in ophthalmology 20040201 |
| Sinus tissue concentration of moxifloxacin after a single oral dose. | The Annals of otology, rhinology, and laryngology 20040201 |
| Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. | Journal of veterinary pharmacology and therapeutics 20040201 |
| Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis. | International journal of antimicrobial agents 20040201 |
| Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis. | Clinical therapeutics 20040201 |
| Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone. | Journal of chemotherapy (Florence, Italy) 20040201 |
| Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. | Stroke 20040101 |
| Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects. | International journal of clinical pharmacology and therapeutics 20040101 |
| Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections. | JPMA. The Journal of the Pakistan Medical Association 20040101 |
| Recurrent tendinitis after treatment with two different fluoroquinolones. | Scandinavian journal of infectious diseases 20040101 |
| Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies. | Drug safety 20040101 |
| [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101 |
| Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. | Scandinavian journal of infectious diseases 20040101 |
| Moxifloxacin: a review of its use in the management of bacterial infections. | Drugs 20040101 |
| Symptom resolution in patients with Mycoplasma pneumoniae pneumonia. | Canadian respiratory journal 20040101 |
| [Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101 |
| Recently introduced antibiotics: a guide for the general physician. | Clinical medicine (London, England) 20040101 |
| [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis]. | Likars'ka sprava 20040101 |
| The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. | American journal of respiratory and critical care medicine 20031201 |
| Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions. | International journal of antimicrobial agents 20031201 |
| In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV. | Diagnostic microbiology and infectious disease 20031201 |
| Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20031201 |
| Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state. | Journal of chemotherapy (Florence, Italy) 20031201 |
| Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility breakpoints too high? | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031115 |
| Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031101 |
| Moxifloxacin-induced Clostridium difficile-associated diarrhea. | Pharmacotherapy 20031101 |
| Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection. | Life sciences 20031010 |
| [Acute exacerbated chronic bronchitis. Antibiotics in comparison]. | MMW Fortschritte der Medizin 20031002 |
| Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii. | The Journal of antimicrobial chemotherapy 20031001 |
| Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. | The Journal of antimicrobial chemotherapy 20031001 |
| Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. | The Journal of antimicrobial chemotherapy 20031001 |
| Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. | The Journal of infectious diseases 20031001 |
| In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. | Diagnostic microbiology and infectious disease 20031001 |
| Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia. | Clinical pharmacology and therapeutics 20031001 |
| Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. | Respiratory medicine 20031001 |
| In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031001 |
| Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity. | Expert review of anti-infective therapy 20031001 |
| Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk. | European journal of pharmacology 20030905 |
| Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. | American journal of ophthalmology 20030901 |
| [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial]. | Archivos de bronconeumologia 20030901 |
| Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. | Antimicrobial agents and chemotherapy 20030801 |
| An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. | Chest 20030801 |
| In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene. | International journal of antimicrobial agents 20030701 |
| A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. | Pharmacotherapy 20030701 |
| The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis. | Chemotherapy 20030701 |
| Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test. | Chemotherapy 20030701 |
| In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030701 |
| Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003. | Circulation 20030617 |
| Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. | The Journal of infectious diseases 20030615 |
| Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones. | The Journal of antimicrobial chemotherapy 20030601 |
| Immunomodulatory effects of quinolones. | The Lancet. Infectious diseases 20030601 |
| In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. | International journal of antimicrobial agents 20030601 |
| New drugs and dosage forms. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030601 |
| Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601 |
| Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. | Journal of chemotherapy (Florence, Italy) 20030601 |
| Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. | Chemotherapy 20030501 |
| National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. | Journal of clinical pathology 20030501 |
| [Playing it safe in bronchopulmonary infections]. | MMW Fortschritte der Medizin 20030501 |
| Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. | The Journal of antimicrobial chemotherapy 20030401 |
| AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model. | The Journal of antimicrobial chemotherapy 20030401 |
| Effects of three fluoroquinolones on QT interval in healthy adults after single doses. | Clinical pharmacology and therapeutics 20030401 |
| Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. | The Journal of antimicrobial chemotherapy 20030301 |
| Experimental pneumococcal pleural empyema model: the effect of moxifloxacin. | The Journal of antimicrobial chemotherapy 20030301 |
| [Pneumococcus and quinolone resistance]. | Archivos de bronconeumologia 20030301 |
| Moxifloxacin-induced Clostridium difficile diarrhea. | The Annals of pharmacotherapy 20030301 |
| [New antibiotics in primary care]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030301 |
| Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results. | Journal of chemotherapy (Florence, Italy) 20030201 |
| Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci. | Antimicrobial agents and chemotherapy 20030101 |
| Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. | Antimicrobial agents and chemotherapy 20030101 |
| Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. | The European respiratory journal 20030101 |
| Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults. | The Journal of laryngology and otology 20030101 |
| [Experience in using the new drug moxifloxacin (Avelox, 'Bayer', Germaniia) in urologic practice]. | Urologiia (Moscow, Russia : 1999) 20030101 |
| [New approaches to antibacterial therapy of infections in the surgical practice]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101 |
| Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection. | Scandinavian journal of infectious diseases 20030101 |
| Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications. | The Journal of international medical research 20030101 |
| Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. | Advances in therapy 20030101 |
| Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. | International journal of antimicrobial agents 20021201 |
| In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. | International journal of antimicrobial agents 20021201 |
| Moxifloxacin: new preparation. A me-too with more cardiac risks. | Prescrire international 20021201 |
| In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea. | Journal of Korean medical science 20021201 |
| Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). | Journal of chemotherapy (Florence, Italy) 20021201 |
| [In vitro activity of moxifloxacin against respiratory pathogens in Latin America]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201 |
| Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. | Journal of pharmaceutical and biomedical analysis 20021107 |
| Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. | International journal of antimicrobial agents 20021101 |
| [Respiratory tract infections. Increasingly more established antibiotics fail]. | MMW Fortschritte der Medizin 20021017 |
| Simultaneous drug allergies. | Allergy 20021001 |
| AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin. | The Journal of antimicrobial chemotherapy 20021001 |
| Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20021001 |
| Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing. | Archives of internal medicine 20020923 |
| Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020901 |
| The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. | Chest 20020901 |
| In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey. | International journal of antimicrobial agents 20020901 |
| Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin. | International journal of antimicrobial agents 20020901 |
| In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. | Diagnostic microbiology and infectious disease 20020801 |
| Calculation of composite recovery time: a new pharmacodynamic parameter. | The Journal of antimicrobial chemotherapy 20020801 |
| Influence of moxifloxacin, comparator drugs and some fractions of pulmonary surfactant on adherence of some respiratory pathogens. | Infection 20020801 |
| Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin. | International journal of antimicrobial agents 20020801 |
| Moxifloxacin-induced acute liver injury. | The American journal of gastroenterology 20020701 |
| Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis. | Antimicrobial agents and chemotherapy 20020601 |
| Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020601 |
| 'There's no such thing as a free meal'. | Connecticut medicine 20020601 |
| Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. | The Journal of infectious diseases 20020501 |
| A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. | The Journal of antimicrobial chemotherapy 20020501 |
| In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis. | Antimicrobial agents and chemotherapy 20020401 |
| Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. | American journal of ophthalmology 20020401 |
| Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. | The Journal of infection 20020401 |
| Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction. | British journal of clinical pharmacology 20020301 |
| Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20020301 |
| Avelox. Respiratory antibiotic now in i.v. form. | Nursing 20020301 |
| In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301 |
| Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. | International journal of antimicrobial agents 20020201 |
| Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom. | Journal of chemotherapy (Florence, Italy) 20020201 |
| Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae. | Journal of chemotherapy (Florence, Italy) 20020201 |
| Improving care for patients with respiratory tract infections. | Journal of chemotherapy (Florence, Italy) 20020201 |
| An updated safety profile of moxifloxacin. | Journal of chemotherapy (Florence, Italy) 20020201 |
| Susceptibility to moxifloxacin and other antimicrobial agents of major pathogens responsible for community acquired respiratory tract infection in Poland. | International journal of antimicrobial agents 20020101 |
| The role of fluoroquinolones in skin and skin structure infections. | American journal of clinical dermatology 20020101 |
| Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020101 |
| E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020101 |
| Moxifloxacin in uncomplicated skin and skin structure infections. | Drugs 20020101 |
| [Perspectives of use of moxifloxacin for treatment of urogenital infections]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101 |
| Anaphylactoid reaction caused by moxifloxacin. | Journal of investigational allergology & clinical immunology 20020101 |
| [Moxifloxacin--antimicrobial activity and pharmacokinetic properties]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101 |
| [Use of avelox in treating urogenital infections in men]. | Urologiia (Moscow, Russia : 1999) 20020101 |
| Demonstration of in vitro antagonism between fusidic acid and quinolones. | The Journal of international medical research 20020101 |
| [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis]. | Vestnik otorinolaringologii 20020101 |
| Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces. | Scandinavian journal of infectious diseases 20020101 |
| Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters. | Chemotherapy 20020101 |
| [Moxifloxacin: results of clinical use]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101 |
| Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. | Antimicrobial agents and chemotherapy 20011201 |
| Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. | The Journal of antimicrobial chemotherapy 20011201 |
| Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. | Journal of cataract and refractive surgery 20011201 |
| Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. | Pharmacotherapy 20011201 |
| [Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201 |
| [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201 |
| Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. | Antimicrobial agents and chemotherapy 20011101 |
| [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community]. | Harefuah 20011101 |
| In vitro activity of moxifloxacin against local bacterial isolates. | Annals of the Academy of Medicine, Singapore 20011101 |
| Moxifloxacin does increase the corrected QT interval. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011015 |
| Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens. | International journal of antimicrobial agents 20011001 |
| Moxifloxacin (Avelox) for the treatment of bacterial skin infections. | Skin therapy letter 20011001 |
| [Third and fourth generation fluoroquinolones]. | Revue medicale de Bruxelles 20011001 |
| Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20011001 |
| Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20010901 |
| Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20010901 |
| The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience. | International journal of clinical practice 20010901 |
| In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20010901 |
| Treatment of Staphylococcus aureus endocarditis using moxifloxacin. | International journal of medical microbiology : IJMM 20010801 |
| [Hypertensive crisis and transitory left brunch block with QT interval prolongation associated to moxifloxacin]. | Medicina clinica 20010707 |
| Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain. | The Journal of antimicrobial chemotherapy 20010701 |
| The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. | Respiratory medicine 20010701 |
| Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. | International journal of antimicrobial agents 20010701 |
| Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010701 |
| Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20010601 |
| Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20010601 |
| Conventional dogma applied to quinolones? Time for a change. | The Journal of antimicrobial chemotherapy 20010601 |
| A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. | Journal of medical microbiology 20010601 |
| Microbial drug resistance and the roles of the new antibiotics. | Cleveland Clinic journal of medicine 20010601 |
| Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. | International journal of clinical practice 20010601 |
| The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. | Journal of cardiovascular pharmacology 20010501 |
| Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance. | International journal of antimicrobial agents 20010501 |
| Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. | European journal of haematology 20010501 |
| A whole blood bactericidal assay for tuberculosis. | The Journal of infectious diseases 20010415 |
| Determination of moxifloxacin in growth media by high-performance liquid chromatography. | Journal of chromatography. B, Biomedical sciences and applications 20010415 |
| Reassuring safety profile of moxifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010401 |
| Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. | The Journal of antimicrobial chemotherapy 20010401 |
| Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. | Diagnostic microbiology and infectious disease 20010401 |
| Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Profile of moxifloxacin drug interactions. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Evaluation of the clinical microbiology profile of moxifloxacin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Clinical perspectives on new antimicrobials: focus on fluoroquinolones. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315 |
| Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. | The Journal of pharmacology and experimental therapeutics 20010301 |
| Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography. | The Journal of antimicrobial chemotherapy 20010301 |
| Moxifloxacin: clinical efficacy and safety. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010301 |
| What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents. | Postgraduate medicine 20010301 |
| In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. | International journal of antimicrobial agents 20010301 |
| Bactericidal activity of moxifloxacin against Staphylococcus aureus. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010301 |
| Activity of oral agents against pediatric isolates of Streptococcus pneumoniae. | Diagnostic microbiology and infectious disease 20010301 |
| [One year moxifloxacin. Still effective in the respiratory tract]. | MMW Fortschritte der Medizin 20010215 |
| Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features. | Expert opinion on pharmacotherapy 20010201 |
| Drug Points: tachycardia associated with moxifloxacin. | BMJ (Clinical research ed.) 20010106 |
| Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. | Antimicrobial agents and chemotherapy 20010101 |
| In vitro development of resistance to three quinolones in Streptococcus pneumoniae. | Chemotherapy 20010101 |
| Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. | Chest 20010101 |
| Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae. | Chemotherapy 20010101 |
| In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101 |
| Bactericidal activity of moxifloxacin against pneumococci. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101 |
| Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration. | Clinical pharmacokinetics 20010101 |
| The influence of age and gender on the pharmacokinetics of moxifloxacin. | Clinical pharmacokinetics 20010101 |
| Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers. | Clinical pharmacokinetics 20010101 |
| Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers. | Clinical pharmacokinetics 20010101 |
| Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. | Clinical pharmacokinetics 20010101 |
| Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers. | Clinical pharmacokinetics 20010101 |
| Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. | Clinical pharmacokinetics 20010101 |
| Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans. | Clinical pharmacokinetics 20010101 |
| Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline. | Clinical pharmacokinetics 20010101 |
| Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers. | Clinical pharmacokinetics 20010101 |
| Chronic obstructive pulmonary disease. | The Journal of international medical research 20010101 |
| Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin. | The Journal of international medical research 20010101 |
| Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients. | The Journal of international medical research 20010101 |
| Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. | The Journal of international medical research 20010101 |
| A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis. | The Journal of international medical research 20010101 |
| In vitro susceptibility study of BMS-284756 against Legionella species. | Diagnostic microbiology and infectious disease 20010101 |
| Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. | Microbial drug resistance (Larchmont, N.Y.) 20010101 |
| [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections]. | Terapevticheskii arkhiv 20010101 |
| Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. | The Journal of antimicrobial chemotherapy 20000501 |
| Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. | Drugs 20000101 |
| Activity of moxifloxacin against mycobacteria. | The Journal of antimicrobial chemotherapy 19990901 |
| Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. | Antimicrobial agents and chemotherapy 19990101 |
| In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. | Antimicrobial agents and chemotherapy 19980801 |
| In vitro activity of BAY 12-8039, a new fluoroquinolone. | Antimicrobial agents and chemotherapy 19970101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.